Metformin, testosterone, or both reduce insulin resistance in obese men with low testosterone: Study Medha Baranwal9 Sept 2022 9:00 AM ISTSpain: A combination of metformin+testosterone, or metformin and testosterone alone reduced insulin resistance at 1 year compared to placebo in obese...
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations Roshni Dhar27 Aug 2022 6:20 PM ISTThrough a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed...
Health Bulletin 27/August/2022 Roshni Dhar27 Aug 2022 5:32 PM ISTHere are the top health news for the day:'Inhumane Torture' and ragging horror at SVN medical college, junior residents made to stand continuously,...
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations Ruchika Sharma25 Aug 2022 5:00 PM ISTNew Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Metformin drastically reduces COVID hospitalization, study shows Dr. Kamal Kant Kohli19 Aug 2022 12:15 PM ISTMetformin is one of most commonly used diabetes drug globally. Researchers at University of Minnesota have found in a new randomized, double blind...
Once Daily Vildagliptin 100 mg sustained-release therapeutically safe, effective as Vildagliptin 50 mg twice daily add on to Metformin in Indian Diabetics Lalhmangaihkimi12 Aug 2022 12:30 PM ISTVildagliptin 100 mg sustained-release once daily is therapeutically safe and effective as Vildagliptin 50 mg tablet twice daily as an add-on to...
Once Daily Vildagliptin 100 mg SR as safe, effective as Vildagliptin 50 mg twice daily add on to Metformin in Indian Diabetics: Discussion on Indian Study Results Dr. Nandita Mohan26 July 2022 12:45 PM IST Vildagliptin, an oral hypoglycemic agent, acts by inhibiting the dipeptidyl peptidase-4 enzyme. The clinical efficacy and safety of vildagliptin...
Metformin use lowers hepatocellular cancer risk in NAFLD patients with diabetes: Study Medha Baranwal15 July 2022 8:00 PM ISTUSA: The use of metformin may lower the risk of hepatocellular cancer (HCC) in patients with type 2 diabetes and nonalcoholic fatty liver disease...
Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India Ruchika Sharma7 July 2022 3:28 PM ISTThe medicines will be available under the brand name SITAZIT, SITAZIT- M, SITAZIT- M ER and SITAZIT D.
NPPA fixes retail price of 84 formulations, Details Susmita Roy2 July 2022 7:14 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Metformin effective for prevention of clozapine-induced weight gain: study Dr. Shravani Dali29 Jun 2022 10:45 AM ISTMetformin is effective for the prevention of clozapine-induced weight gain according to a recent study published in the Acta Psychiatrica...
Glenmark gets CDSCO Panel nod to study antidiabetic FDC containing Dapagliflozin, Sitagliptin, Metformin Susmita Roy27 Jun 2022 6:15 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
